FDA Announces Nationwide Recall Of Cetirizine Tablets Due To Potential Ranitidine Contamination

A nationwide recall has been issued for four lots of Cetirizine Hydrochloride Tablets USP 5 mg after the manufacturer discovered potential cross-contamination with ranitidine, according to the U.S. Food and Drug Administration (FDA). Unique Pharmaceutical Laboratories, a division of J. B. Chemicals & Pharmaceuticals Ltd., voluntarily recalled the affected products to the consumer level after […]

The post FDA Announces Nationwide Recall Of Cetirizine Tablets Due To Potential Ranitidine Contamination appeared first on Dallas Express.